Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00877513 · ClinicalTrials.gov registry record · NA
Insulin Resistance in Smokers Undergoing Smoking Cessation
A NA study, sponsored by Charles Drew University of Medicine and Science.
- Terminated
- Registry status
- NA
- Development phase
- 103
- Enrollment target
NCT00877513: Clinical Trial NA study, sponsored by Charles Drew University of Medicine and Science.
NCT00877513 is a NA study that was terminated before completion, run by Charles Drew University of Medicine and Science. The registered enrollment target is 103 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (93% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00877513, a NA study, was terminated before completion, sponsored by Charles Drew University of Medicine and Science.
- TERMINATED
- Registry status
- NA
- Development phase
- 103 participants
- Enrollment target
Study Summary
Cigarette smoking increases CVD risk and worsens insulin resistance, but also contributes to weight loss; smoking cessation reduces CVD risk and improves insulin sensitivity, but also contributes to weight gain. The mechanisms that underlie these metabolic changes of cigarette smoking and smoking cessation on insulin resistance, body composition, and fat distribution are poorly understood.
Interventions
- BEHAVIORAL Smoking cessation
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 103 participants |
| Start Date | 2009-02 |
| Est. Completion | 2013-12 |
| Phase | NA |
Why NCT00877513 stopped before completion
NCT00877513 is an interventional study that assigns participants to a tested intervention. The registered 103 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (93% lower).
The record links to 0 conditions, and to 1 intervention - of which Smoking cessation is the first listed.
NCT00877513 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00877513 about?
NCT00877513 is a clinical study titled "Insulin Resistance in Smokers Undergoing Smoking Cessation". Cigarette smoking increases CVD risk and worsens insulin resistance, but also contributes to weight loss; smoking cessation reduces CVD risk and improves insulin sensitivity, but also contributes to weight gain. The mechanisms that underlie these metabolic changes of cigarette smoking and smoking ce...
What is the current status of trial NCT00877513?
This trial is currently terminated. It is a NA study. The enrollment target is 103 participants. The study started on 2009-02. Estimated completion is 2013-12.
What interventions are being tested in trial NCT00877513?
The interventions under investigation include: Smoking cessation (BEHAVIORAL).
Who is sponsoring clinical trial NCT00877513?
This trial is sponsored by Charles Drew University of Medicine and Science, which has 30 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT00877513's enrollment target sits among peer trials
103 837th of 2000 higher than 1,164 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04690348 · 103 participants · Phase 2
Intracavitary Carrier-embedded Cs131 Brachytherapy for Recurrent Brain Metastases: a Randomized Phase II Study
- NCT05282277 · 103 participants · Phase 4
Examining the Effects of Estradiol on Neural and Molecular Response to Reward
- NCT05566769 · 103 participants · NA
Performance and Safety of a Digital Tool for Unsupervised Self-assessment of NMOSD
- NCT05834478 · 103 participants · Phase 3
Non-invasive Vagal Nerve Stimulation in Opioid Use Disorders UH3
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia